Nuvalent share price today

(NUVL)

Nuvalent share price is $84.22 & ₹7,156.68 as on 21 Dec 2024, 2.30 'hrs' IST

$84.22

▲

-0.42

(-0.5%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Nuvalent share price in Dollar and Rupees. Guide to invest in Nuvalent from India. Also see the sentimental analysis on Indian investors investing in Nuvalent. Get details on the Indian mutual funds that are investing in Nuvalent. Get Analyst recommendations and forecasts along with all the Nuvalent's financials.

Nuvalent share price movements

Today's Low: $82.81
Today's High: $87.14
$84.22
1.68%
Downside
Day's Volatility :4.97%
Upside
3.35%
52 Weeks Low: $61.80
52 Weeks High: $113.51
$84.22
26.63%
Downside
52 Weeks Volatility :45.56%
Upside
25.8%

Nuvalent Returns

Period	Nuvalent, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.47%	-11.1%	0.0%
6 Months	4.47%	-6.0%	0.0%
1 Year	13.35%	2.7%	0.0%
3 Years	338.19%	0.6%	-19.7%

Nuvalent Key Statistics

in dollars & INR

Previous Close	$84.64
Open	$83.49
Today's High	$87.14
Today's Low	$82.805
Market Capitalization	$6.0B
Today's Volume	$991.3K
52 Week High	$113.51
52 Week Low	$61.795
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-3.47
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-29.57%

How to invest in Nuvalent from India?

It is very easy for Indian residents to invest directly in Nuvalent from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nuvalent stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nuvalent or NUVL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nuvalent or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nuvalent shares which would translate to 0.010 fractional shares of Nuvalent as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Nuvalent, in just a few clicks!

Returns in Nuvalent for Indian investors in Rupees

Investment Value

₹1,00,000

Nuvalent investment value today

Current value as on today

₹1,15,547

Returns

₹15,547

(+15.55%)

Returns from Nuvalent Stock

₹13,351 (+13.35%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Nuvalent

267%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Nuvalent on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 267% more investors are searching Nuvalent in the last 30 days versus the previous period.

Global Institutional Holdings in Nuvalent

Deerfield Management Co
28.14%
FMR Inc
13.59%
Paradigm Biocapital Advisors LP
7.04%
Vanguard Group Inc
5.82%
BlackRock Inc
4.26%
Perceptive Advisors LLC
4.19%

Analyst Recommendation on Nuvalent

Buy

93%Buy

6%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Nuvalent(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Nuvalent

What analysts predicted

Upside of 37.14%

Current:

$84.22

Target:

$115.50

Insights on Nuvalent

Price Movement
In the last 3 years, NUVL stock has moved up by 307.5%
NUVL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 16.1%

Nuvalent Technicals Summary

Sell

Neutral

Buy

Nuvalent is currently in a neutral trading position according to technical analysis indicators.

Nuvalent Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nuvalent, Inc.	-11.28%	4.47%	13.35%	338.19%	349.17%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nuvalent, Inc.	NA	NA	NA	-3.72	-0.3	-0.19	NA	15.81
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nuvalent, Inc.	Buy	$6.0B	349.17%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

About Nuvalent

nuvalent is improving human health by developing breakthrough small molecule therapeutics that engage biological targets in new ways using cutting-edge chemical insights. by expanding the universe of targets that interact with small molecules, we are generating therapeutics with activities not previously possible, including modulation of ‘undruggable’ targets. our unique approach is leading to first-in-class and best-in-class small molecule therapeutics that will significantly impact patient’s lives.

Organization	Nuvalent
Employees	127
CEO	Dr. James R. Porter Ph.D.
Industry	Services

Management People of Nuvalent

Name	Title
Dr. James R. Porter Ph.D.	CEO, President & Director
Prof. Matthew D. Shair Ph.D.	Founder, Head of Scientific Advisory Board & Director
Ms. Alexandra Balcom CPA, M.B.A.	CFO & Treasurer
Dr. Christopher D. Turner M.D.	Chief Medical Officer
Dr. Benjamin Lane Ph.D.	Senior Vice President of Technical Operations
Mr. Henry Pelish Ph.D.	Chief Scientific Officer
Ms. Deborah Ann Miller J.D., Ph.D.	Chief Legal Officer & Secretary
Mr. Matthew Metivier	Senior Vice President of Human Resources
Ms. Darlene Noci	Chief Development Officer
Mr. John Soglia Ph.D.	Senior Vice President of Translational Development

Important FAQs about investing in Nuvalent from India :

What is Nuvalent share price today?

Nuvalent share price today stands at $84.22, Open: $83.49 ; Previous Close: $84.64 ; High: $87.14 ; Low: $82.81 ; 52 Week High: $113.51 ; 52 Week Low: $61.80. The stock opens at $83.49, after a previous close of $84.64. The stock reached a daily high of $87.14 and a low of $82.81, with a 52-week high of $113.51 and a 52-week low of $61.80.

Can Indians buy Nuvalent shares?

Yes, Indians can invest in the Nuvalent (NUVL) from India.

With INDmoney, you can buy Nuvalent at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Nuvalent at zero transaction cost.

How can I buy Nuvalent shares from India?

It is very easy to buy Nuvalent from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nuvalent be purchased?

Yes, you can buy fractional shares of Nuvalent with INDmoney app.

What are the documents required to start investing in Nuvalent stocks?

To start investing in Nuvalent, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.